Pemazyre 4
Pemazyre 4 is a medicine authorised by Swissmedic under authorisation number 68143. The authorisation holder is Incyte Biosciences International Sàrl. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 July 2021 and the authorisation is limited until 23 July 2030. ATC code L01EN02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68143 |
|---|---|
| Name | Pemazyre 4 |
| Full name | Pemazyre 4,5 mg, comprimés |
| Authorisation holder | Incyte Biosciences International Sàrl |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EN02 |
| First authorisation | 13 July 2021 |
| Authorisation validity | 23 July 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pemazyre 4,5 mg, comprimés | A | 13 July 2021 |
| 2 | Pemazyre 9 mg, comprimés | A | 13 July 2021 |
| 3 | Pemazyre 13,5 mg, comprimés | A | 13 July 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 14 | Tablette(n) | L01EN02 | 07.16.1. | A |
| 2 | 28 | Tablette(n) | L01EN02 | 07.16.1. | A |
| 3 | 14 | Tablette(n) | L01EN02 | 07.16.1. | A |
| 4 | 28 | Tablette(n) | L01EN02 | 07.16.1. | A |
| 5 | 14 | Tablette(n) | L01EN02 | 07.16.1. | A |
| 6 | 28 | Tablette(n) | L01EN02 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Pemazyre 4 authorised in Switzerland?
Yes. Pemazyre 4 is authorised by Swissmedic under authorisation number 68143, data as of 01 September 2026. The authorisation is limited until 23 July 2030.
Which dispensing category does Pemazyre 4 have?
Pemazyre 4 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Pemazyre 4?
The authorisation holder is Incyte Biosciences International Sàrl. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.